ScreenerHero

ASBPWAspire Biopharma Holdings Inc. Warrant

NAS · US · Healthcare · Biotechnology · aspirebiolabs.com
0.0131USD-37.62%Mkt Cap: —P/E: —

Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product th…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap—
Enterprise Value—
Revenue (TTM)97.66K $
Gross Profit-116 $
Net Income (TTM)-24.48M $
Revenue/Share0.2950 USD
Last Price0.0131 USD
Fiscal Year End—
MR Quarter—
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.00
EPS (TTM)—
EPS (Forward)—
52W Range
0.01300% of range18.00
52W High18.00 USD
52W Low0.0130 USD
Profitability
Gross Margin-1.87%
Oper. Margin-3880.58%
EBITDA Margin0.00%
Profit Margin-394725.06%
ROE383.93%
ROA-1865.68%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.92M $
CapEx (TTM)—
FCF Margin7609.32%
FCF Yield—
Net Debt-12.17M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.81
Current Ratio7.99
Quick Ratio7.22
Book Value/Sh9.078 USD
Cash/Share8.675 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateMay 11, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float1.09M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta0.11
S&P 52W Chg18.16%
Avg Vol (30d)16.79K
Avg Vol (10d)—
Technical Indicators
RSI (14)44.4
MACD-0.0254
MACD Signal-0.0361
MACD Hist.+0.0106
BB Upper0.0257 USD
BB Middle0.0203 USD
BB Lower0.0149 USD
BB Width53.33%
ATR (14)0.0257 USD
Vol Ratio (20d)0.21x